Fellowship · Bronx, NY
Sponsored by Montefiore Medical Center/Albert Einstein College of Medicine
Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome.
Transplantation and cellular therapy · 2023 · 331 citations · Kris Mahadeo
Navigating financial toxicity in patients with cancer: A multidisciplinary management approach.
CA: a cancer journal for clinicians · 2022 · 245 citations · Michael Roth
American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19.
Blood advances · 2021 · 302 citations · Jennifer Davila
Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas.
The New England journal of medicine · 2021 · 288 citations · Allison Martin
Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy.
Transplantation and cellular therapy · 2021 · 172 citations · Ellen Fraint
Haploidentical Bone Marrow Transplantation for Sickle Cell Disease.
NEJM evidence · 2025 · 39 citations · Kris Mahadeo
Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial.
The Lancet. Oncology · 2024 · 75 citations · Kris Mahadeo
Autologous CD33-CAR-T cells for treatment of relapsed/refractory acute myelogenous leukemia.
Leukemia · 2021 · 177 citations · Kris Mahadeo